biostudies-literatureUnknown60(5)Mascarenhas JNHLBI NIH HHSNational Cancer InstituteNCI NIH HHSLeukemia & lymphoma1343-1345https://www.ebi.ac.uk/biostudies/studies/S-EPMC6530779biostudies-literaturePhase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis.PMC6530779P01CA108671P01 HL053762P01 CA108671Weinberg RDueck ACPrice LMascarenhas JTremblay DHexner ESandy LGoldberg JDSilverman LRKessler CKosiorek HPahl HHoffman RBaer MRfalsePhase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis.2019-01-01T00:00:00Z2019 May2026-05-02T00:09:54.559Z2025-04-21T16:06:03.383ZS-EPMC65307793066826610.1080/10428194.2018.1532509